Clinical Roundup Vanderbilt study: World Trade Center responders at higher risk for blood cancer-associated mutations March 11, 2022Vol.48 No.10
Clinical Roundup NYU study: Alzheimer’s protein protects metastasized melanoma cells in the brain March 11, 2022Vol.48 No.10
Clinical Roundup City of Hope’s investigational COVID-19 vaccine generates robust immune response March 11, 2022Vol.48 No.10
Clinical Roundup Boston Cell Standards establishes Consortium for Analytic Standardization in Immunohistochemistry March 11, 2022Vol.48 No.10
Clinical Roundup Karmanos Cancer Institute, Lifeguard Health Networks to pilot virtual care platform March 11, 2022Vol.48 No.10
Drugs & Targets FDA approves Opdivo and platinum-doublet chemotherapy for early-stage NSCLC March 11, 2022Vol.48 No.10
Drugs & Targets FDA grants priority review to Tibsovo in combination with azacitidine in previously untreated IDH1-mutated AML March 11, 2022Vol.48 No.10
Drugs & Targets FDA clinical trial guidances touch on Biden administration’s goals for advancing development of cancer treatments March 11, 2022Vol.48 No.10
Drugs & Targets Six months after court-ordered deadline, FDA hasn’t ruled on major e-cigarette manufacturers’ product applications, advocates say March 11, 2022Vol.48 No.10
